Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

2008

Aims To evaluate the influence of cytochrome P450 (CYP) 3A4 inhibitors on the clinical pharmacokinetics of maraviroc, a novel CCR5 antagonist.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

25

References

75

Citations